Cerevel Therapeutics Holdings Inc
NASDAQ:CERE
Cerevel Therapeutics Holdings Inc
NASDAQ:CERE
Price:
40.27 USD
0.62%
Market Closed
Updated:
Jun 11, 2024
Cerevel Therapeutics Holdings Inc
Change in Working Capital
|
Cerevel Therapeutics Holdings Inc
Change in Working Capital Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Cerevel Therapeutics Holdings Inc
NASDAQ:CERE
|
Change in Working Capital
$16.1m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Change in Working Capital
$3.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
38%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Change in Working Capital
-$2.2B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-5%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Change in Working Capital
-$422m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-7%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Change in Working Capital
-$275.3m
|
CAGR 3-Years
-158%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Change in Working Capital
$105.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Cerevel Therapeutics Holdings Inc's Change in Working Capital?
Change in Working Capital
16.1m
USD
16.1m
USD
Based on the financial report for Dec 31, 2023, Cerevel Therapeutics Holdings Inc's Change in Working Capital amounts to 16.1m USD.
What is Cerevel Therapeutics Holdings Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 3Y
-3%
-3%
Over the last year, the Change in Working Capital growth was -43%. The average annual Change in Working Capital growth rates for Cerevel Therapeutics Holdings Inc have been -3% over the past three years .
You don't have any saved screeners yet
